tetano
Editor, Senior Moderator
BMC Med
. 2020 Sep 7;18(1):274.
doi: 10.1186/s12916-020-01761-0.
The association between frailty and severe disease among COVID-19 patients aged over 60 years in China: a prospective cohort study
Yao Ma[SUP] 1 2 [/SUP], Lisha Hou[SUP] 1 [/SUP], Xiufang Yang[SUP] 2 3 [/SUP], Zhixin Huang[SUP] 4 [/SUP], Xue Yang[SUP] 1 [/SUP], Na Zhao[SUP] 5 [/SUP], Min He[SUP] 2 6 [/SUP], Yixin Shi[SUP] 7 [/SUP], Yan Kang[SUP] 8 9 [/SUP], Jirong Yue[SUP] 10 11 [/SUP], Chenkai Wu[SUP] 12 [/SUP]
Affiliations
Abstract
Background: The coronavirus disease 2019 (COVID-19) has been a pandemic worldwide. Old age and underlying illnesses are associated with poor prognosis among COVID-19 patients. However, whether frailty, a common geriatric syndrome of reduced reserve to stressors, is associated with poor prognosis among older COVID-19 patients is unknown. The aim of our study is to investigate the association between frailty and severe disease among COVID-19 patients aged ≥ 60 years.
Methods: A prospective cohort study of 114 hospitalized older patients (≥ 60 years) with confirmed COVID-19 pneumonia was conducted between 7 February 2020 and 6 April 2020. Epidemiological, demographic, clinical, laboratory, and outcome data on admission were extracted from electronic medical records. All patients were assessed for frailty on admission using the FRAIL scale, in which five components are included: fatigue, resistance, ambulation, illnesses, and loss of weight. The outcome was the development of the severe disease within 60 days. We used the Cox proportional hazards models to identify the unadjusted and adjusted associations between frailty and severe illness. The significant variables in univariable analysis were included in the adjusted model.
Results: Of 114 patients, (median age, 67 years; interquartile range = 64-75 years; 57 [50%] men), 39 (34.2%), 39 (34.2%), and 36 (31.6%) were non-frail, pre-frail, and frail, respectively. During the 60 days of follow-up, 43 severe diseases occurred including eight deaths. Four of 39 (10.3%) non-frail patients, 15 of 39 (38.5%) pre-frail patients, and 24 of 36 (66.7%) frail patients progressed to severe disease. After adjustment of age, sex, body mass index, haemoglobin, white blood count, lymphocyte count, albumin, CD8+ count, D-dimer, and C-reactive protein, frailty (HR = 7.47, 95% CI 1.73-32.34, P = 0.007) and pre-frailty (HR = 5.01, 95% CI 1.16-21.61, P = 0.03) were associated with a higher hazard of severe disease than the non-frail.
Conclusions: Frailty, assessed by the FRAIL scale, was associated with a higher risk of developing severe disease among older COVID-19 patients. Our findings suggested that the use of a clinician friendly assessment of frailty could help in early warning of older patients at high-risk with severe COVID-19 pneumonia.
Keywords: COVID-19; Frailty; Older; Prospective study; Severe disease.
. 2020 Sep 7;18(1):274.
doi: 10.1186/s12916-020-01761-0.
The association between frailty and severe disease among COVID-19 patients aged over 60 years in China: a prospective cohort study
Yao Ma[SUP] 1 2 [/SUP], Lisha Hou[SUP] 1 [/SUP], Xiufang Yang[SUP] 2 3 [/SUP], Zhixin Huang[SUP] 4 [/SUP], Xue Yang[SUP] 1 [/SUP], Na Zhao[SUP] 5 [/SUP], Min He[SUP] 2 6 [/SUP], Yixin Shi[SUP] 7 [/SUP], Yan Kang[SUP] 8 9 [/SUP], Jirong Yue[SUP] 10 11 [/SUP], Chenkai Wu[SUP] 12 [/SUP]
Affiliations
- PMID: 32892742
- DOI: 10.1186/s12916-020-01761-0
Abstract
Background: The coronavirus disease 2019 (COVID-19) has been a pandemic worldwide. Old age and underlying illnesses are associated with poor prognosis among COVID-19 patients. However, whether frailty, a common geriatric syndrome of reduced reserve to stressors, is associated with poor prognosis among older COVID-19 patients is unknown. The aim of our study is to investigate the association between frailty and severe disease among COVID-19 patients aged ≥ 60 years.
Methods: A prospective cohort study of 114 hospitalized older patients (≥ 60 years) with confirmed COVID-19 pneumonia was conducted between 7 February 2020 and 6 April 2020. Epidemiological, demographic, clinical, laboratory, and outcome data on admission were extracted from electronic medical records. All patients were assessed for frailty on admission using the FRAIL scale, in which five components are included: fatigue, resistance, ambulation, illnesses, and loss of weight. The outcome was the development of the severe disease within 60 days. We used the Cox proportional hazards models to identify the unadjusted and adjusted associations between frailty and severe illness. The significant variables in univariable analysis were included in the adjusted model.
Results: Of 114 patients, (median age, 67 years; interquartile range = 64-75 years; 57 [50%] men), 39 (34.2%), 39 (34.2%), and 36 (31.6%) were non-frail, pre-frail, and frail, respectively. During the 60 days of follow-up, 43 severe diseases occurred including eight deaths. Four of 39 (10.3%) non-frail patients, 15 of 39 (38.5%) pre-frail patients, and 24 of 36 (66.7%) frail patients progressed to severe disease. After adjustment of age, sex, body mass index, haemoglobin, white blood count, lymphocyte count, albumin, CD8+ count, D-dimer, and C-reactive protein, frailty (HR = 7.47, 95% CI 1.73-32.34, P = 0.007) and pre-frailty (HR = 5.01, 95% CI 1.16-21.61, P = 0.03) were associated with a higher hazard of severe disease than the non-frail.
Conclusions: Frailty, assessed by the FRAIL scale, was associated with a higher risk of developing severe disease among older COVID-19 patients. Our findings suggested that the use of a clinician friendly assessment of frailty could help in early warning of older patients at high-risk with severe COVID-19 pneumonia.
Keywords: COVID-19; Frailty; Older; Prospective study; Severe disease.